Logo image of 1SANX.MI

BANCO SANTANDER SA (1SANX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1SANX - ES0113900J37 - Common Stock

8.934 EUR
+0 (+0.02%)
Last: 11/20/2025, 7:00:00 PM
Fundamental Rating

3

1SANX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 106 industry peers in the Banks industry. 1SANX may be in some trouble as it scores bad on both profitability and health. 1SANX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1SANX was profitable.
Of the past 5 years 1SANX 4 years were profitable.
1SANX had a positive operating cash flow in 4 of the past 5 years.
1SANX.MI Yearly Net Income VS EBIT VS OCF VS FCF1SANX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B

1.2 Ratios

With a Return On Assets value of 0.74%, 1SANX perfoms like the industry average, outperforming 46.79% of the companies in the same industry.
1SANX has a better Return On Equity (13.46%) than 67.89% of its industry peers.
Industry RankSector Rank
ROA 0.74%
ROE 13.46%
ROIC N/A
ROA(3y)0.62%
ROA(5y)0.36%
ROE(3y)11.71%
ROE(5y)6.74%
ROIC(3y)N/A
ROIC(5y)N/A
1SANX.MI Yearly ROA, ROE, ROIC1SANX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

1SANX has a worse Profit Margin (19.79%) than 66.06% of its industry peers.
In the last couple of years the Profit Margin of 1SANX has grown nicely.
The Operating Margin and Gross Margin are not available for 1SANX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 19.79%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.17%
PM growth 5Y10.55%
GM growth 3YN/A
GM growth 5YN/A
1SANX.MI Yearly Profit, Operating, Gross Margins1SANX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1

2. Health

2.1 Basic Checks

1SANX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1SANX has been reduced compared to 1 year ago.
The number of shares outstanding for 1SANX has been reduced compared to 5 years ago.
The debt/assets ratio for 1SANX is higher compared to a year ago.
1SANX.MI Yearly Shares Outstanding1SANX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1SANX.MI Yearly Total Debt VS Total Assets1SANX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.13 is on the high side and indicates that 1SANX has dependencies on debt financing.
1SANX has a worse Debt to Equity ratio (3.13) than 70.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.13
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.44%
1SANX.MI Yearly LT Debt VS Equity VS FCF1SANX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1SANX.MI Yearly Current Assets VS Current Liabilites1SANX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.22% over the past year.
The Earnings Per Share has been growing by 16.42% on average over the past years. This is quite good.
Looking at the last year, 1SANX shows a small growth in Revenue. The Revenue has grown by 0.08% in the last year.
The Revenue has been growing slightly by 3.17% on average over the past years.
EPS 1Y (TTM)16.22%
EPS 3Y20.14%
EPS 5Y16.42%
EPS Q2Q%15%
Revenue 1Y (TTM)0.08%
Revenue growth 3Y8.95%
Revenue growth 5Y3.17%
Sales Q2Q%0.87%

3.2 Future

1SANX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.29% yearly.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y16.96%
EPS Next 2Y13.07%
EPS Next 3Y12.69%
EPS Next 5Y3.29%
Revenue Next Year0.99%
Revenue Next 2Y0.31%
Revenue Next 3Y1.46%
Revenue Next 5Y2.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1SANX.MI Yearly Revenue VS Estimates1SANX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
1SANX.MI Yearly EPS VS Estimates1SANX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.39, the valuation of 1SANX can be described as very reasonable.
Based on the Price/Earnings ratio, 1SANX is valued a bit cheaper than the industry average as 61.47% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1SANX to the average of the S&P500 Index (26.56), we can say 1SANX is valued rather cheaply.
1SANX is valuated reasonably with a Price/Forward Earnings ratio of 9.07.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SANX indicates a rather cheap valuation: 1SANX is cheaper than 84.40% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.79. 1SANX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.39
Fwd PE 9.07
1SANX.MI Price Earnings VS Forward Price Earnings1SANX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1SANX.MI Per share data1SANX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

1SANX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1SANX's earnings are expected to grow with 12.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)0.63
EPS Next 2Y13.07%
EPS Next 3Y12.69%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.92%, 1SANX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.33, 1SANX's dividend is way lower than its industry peers. On top of this 85.32% of the companies listed in the same industry pay a better dividend than 1SANX!
1SANX's Dividend Yield is comparable with the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of 1SANX decreases each year by -2.45%.
Dividend Growth(5Y)-2.45%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y13.07%
EPS Next 3Y12.69%
1SANX.MI Yearly Income VS Free CF VS Dividend1SANX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

BANCO SANTANDER SA

BIT:1SANX (11/20/2025, 7:00:00 PM)

8.934

+0 (+0.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners37.87%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap131.75B
Revenue(TTM)68.73B
Net Income(TTM)13.60B
Analysts80
Price Target9.63 (7.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0.19
Dividend Growth(5Y)-2.45%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.73%
Min EPS beat(2)-0.99%
Max EPS beat(2)4.46%
EPS beat(4)3
Avg EPS beat(4)12.15%
Min EPS beat(4)-0.99%
Max EPS beat(4)43.7%
EPS beat(8)5
Avg EPS beat(8)7.69%
EPS beat(12)8
Avg EPS beat(12)5.75%
EPS beat(16)12
Avg EPS beat(16)5.35%
Revenue beat(2)0
Avg Revenue beat(2)-1.41%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)-1.28%
Revenue beat(4)2
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.06%
Revenue beat(8)3
Avg Revenue beat(8)-0.38%
Revenue beat(12)6
Avg Revenue beat(12)3.71%
Revenue beat(16)10
Avg Revenue beat(16)9.94%
PT rev (1m)5.1%
PT rev (3m)15.85%
EPS NQ rev (1m)3.01%
EPS NQ rev (3m)11.61%
EPS NY rev (1m)0.85%
EPS NY rev (3m)2.48%
Revenue NQ rev (1m)1.55%
Revenue NQ rev (3m)3.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 10.39
Fwd PE 9.07
P/S 1.92
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)0.86
EY9.63%
EPS(NY)0.98
Fwd EY11.02%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.66
BVpS6.85
TBVpS5.68
PEG (NY)0.61
PEG (5Y)0.63
Graham Number11.52
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 13.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.79%
GM N/A
FCFM N/A
ROA(3y)0.62%
ROA(5y)0.36%
ROE(3y)11.71%
ROE(5y)6.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.17%
PM growth 5Y10.55%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 3.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC5.44%
ROIC/WACCN/A
Cap/Depr(3y)371.12%
Cap/Depr(5y)366.07%
Cap/Sales(3y)17.82%
Cap/Sales(5y)18.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.22%
EPS 3Y20.14%
EPS 5Y16.42%
EPS Q2Q%15%
EPS Next Y16.96%
EPS Next 2Y13.07%
EPS Next 3Y12.69%
EPS Next 5Y3.29%
Revenue 1Y (TTM)0.08%
Revenue growth 3Y8.95%
Revenue growth 5Y3.17%
Sales Q2Q%0.87%
Revenue Next Year0.99%
Revenue Next 2Y0.31%
Revenue Next 3Y1.46%
Revenue Next 5Y2.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-302.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-581.65%
OCF growth 3YN/A
OCF growth 5YN/A

BANCO SANTANDER SA / 1SANX.MI FAQ

Can you provide the ChartMill fundamental rating for BANCO SANTANDER SA?

ChartMill assigns a fundamental rating of 3 / 10 to 1SANX.MI.


Can you provide the valuation status for BANCO SANTANDER SA?

ChartMill assigns a valuation rating of 5 / 10 to BANCO SANTANDER SA (1SANX.MI). This can be considered as Fairly Valued.


What is the profitability of 1SANX stock?

BANCO SANTANDER SA (1SANX.MI) has a profitability rating of 3 / 10.


What are the PE and PB ratios of BANCO SANTANDER SA (1SANX.MI) stock?

The Price/Earnings (PE) ratio for BANCO SANTANDER SA (1SANX.MI) is 10.39 and the Price/Book (PB) ratio is 1.3.


How financially healthy is BANCO SANTANDER SA?

The financial health rating of BANCO SANTANDER SA (1SANX.MI) is 1 / 10.